The factors such as rising number of surgeries such as cardiac, orthopaedic and general surgeries, technological advancements in drug delivery systems, rising launch of new anaesthetic drugs, surgical complexities and patient safety expectations, changing in anaesthesiology techniques are likely to contribute to the healthy growth of the market.
New York, July, 2021: Axiom Market Research & Consulting™ added a report on global general anaesthetic drugs market which includes study on product, mode of purchase, application, and end user across various countries of key regions across the globe. The global general anaesthetic drugs market was projected to grow at a CAGR of 3.6% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the general anaesthetic drug market.
Get Sample PDF Copy @ https://www.axiommrc.com/rqs/10725-general-anaesthetic-drug-market-report
The report analyses the global general anaesthetic drugs industry based on drug molecules, route of administration, end user and geography. Various drug molecules covered in global general anaesthetic drugs market are isoflurane, desflurane, sevoflurane, ketamine, thiopental, opioids, propofol and other. By route of administration, the market is segmented into inhalational and intravenous routes of administrations. Based on end user, the market is segmented into hospitals, speciality clinics, ambulatory surgical centres and other end users. The global general anaesthetic drug market is studied across various key regions such as, North America, Europe, Asia Pacific and Rest of the World.
The key competitors of this market include Baxter International Inc. (Us), Hikma Pharmaceuticals Plc (Uk), Pfizer Inc. (Us), Piramal Enterprises Limited (India), Abbvie (Us), Fresenius Se & Co. Kgaa (Germany), Par Pharmaceutical (Us), Teva Pharmaceuticals (Israel), Viatris/Mylan (Us), Novartis Ag (Us), Abbott Laboratories (Us), Astrazeneca Plc (Us), F. Hoffmann-La Roche (Switzerland), Glaxosmithkline Plc (Uk), Gilead Sciences Inc. (Us), Bayer Ag (Germany), Merck & Co. Inc. (Germany), Sanofi (France), Heritage Pharmaceuticals Inc. (Us), Akorn (Us) and Apotex (Canada) among others.
General Anaesthetic Drugs Market Regional Trends
North America is expected to witness the fastest growth in upcoming years owing to hold significant share in terms of value. The US and Canada are expected to dominate the market in the upcoming years, The key factors that attributed market growth are increasing adoption of novel therapeutics, new product launch, increasing rate of surgeries, increasing demand of advanced technologies and homecare facilities.
General Anaesthetic Drugs Market Segmental Highlights
- The propofol segment is expected to dominate the general anaesthetic drugs market during the forecast period 2021 to 2027. The growth of this segment is rapidly improving owing to wide application in initiating and maintenance of surgical sedation. And uses in critical care surgeries including patient with COVID-19 patients is further boosting the market growth.
- In 2020, intravenous segment accounted for the major market share. The minimal side effects than the inhalational route, less cost and no requirement of any special equipment for administration. This make them more demandable in the global market.
- Hospital end user segment dominated the market in 2020. Major factors such as rising footfall of patient in hospitals, rising number of surgeries, adoption of technological advanced healthcare facilities, rising population are accredited to the growth of the market.
- North America dominated general anaesthetic drugs market in 2020 and is expected to witness the fastest growth in upcoming years.
Purchase This Report @ https://www.axiommrc.com/buy_now/10725-general-anaesthetic-drug-market-report
Research Objectives of General Anaesthetic Drugs Market Report:
- Analyzing the outlook of the market with the recent trends and Porter’s five forces analysis
- Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period
- Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects
- Country-level analysis, integrating the demand and supply forces that are influencing the growth of the general anaesthetic drugs market
- Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years
- Comprehensive company profiles, covering the product offerings, key financial information, recent developments and strategies employed by the major market players
Our Other Related Reports:
Surgical Power Tool Market:
https://www.axiommrc.com/product/10683-Surgical-Power-Tool-Market-Report
Cold Pain Therapy Market:
https://www.axiommrc.com/product/10636-cold-pain-therapy-market-report
About Us:
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.
Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.
Axiom MRC with its experienced team of research and data analysts, has delivered more than 700+ Market Research Projects, 2100+ Data Analytics Projects, 260+ Business Support Projects and has a 400+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.
For more information, visit Axiom Market Research & Consulting™ at www.axiommrc.com
Contact Us:
Axiom Market Research & Consulting
United States
3 Germany Dr.Ste 4 – 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: sales@axiommrc.com
Website: https://www.axiommrc.com
Contact Information:
+ 1 (845) 875-9786
Tags:
, Menafn, IPS, Reportedtimes, Research Newswire, English
Contact Information:
+ 1 (845) 875-9786
The post General Anaesthetic Drugs Market to Witness a CAGR of 3.6% during 2021 to 2027 Globally- AXIOM MRC appeared first on Financial Market Brief.
